After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...
Hims & Hers Health, Inc. could see more upside in partnerships and international expansion. Click here to read an analysis of ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...
Medpage Today on MSN
Semaglutide's MASH Benefits Extend Beyond Weight Loss
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.
This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...
The White Houes may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...
An experiment at the State University of Campinas found that FGF19, a substance produced in the intestine, acts on specific ...
The Clipper Barn, located at 3935 Highway 319, is the second barbershop Andrew and Kristina Tartaglia have owned and operated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results